Search research articles
Contact Us
Filters
Showing results (601-610 of 647) with videos related to
Page
of 65
Sort By:
Cell Research
|
January 14, 2015
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
Dalil Hannani, Marie Vétizou, David Enot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer
Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, et al.
Nature
|
July 24, 2024
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P Ward, et al.
Nature Medicine
|
November 28, 2018
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2022
Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2021
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Nature Medicine
|
October 13, 2020
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Jianjun Gao, Neema Navai, Omar Alhalabi, et al.
Nature
|
November 28, 2014
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M Gubin, Xiuli Zhang, Heiko Schuster, et al.
Cancer Discovery
|
December 1, 2020
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
Spencer C Wei, Wouter C Meijers, Margaret L Axelrod, et al.
Nature Communications
|
August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Page
of 65
Search research articles
Search
Showing results (601-610 of 647) with videos related to
Sort By:
Page
of 65
Cell Research
|
January 14, 2015
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25
Dalil Hannani, Marie Vétizou, David Enot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 29, 2024
A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer
Ana M Aparicio, Rebecca S S Tidwell, Shalini S Yadav, et al.
Nature
|
July 24, 2024
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Hussein Sultan, Yoshiko Takeuchi, Jeffrey P Ward, et al.
Nature Medicine
|
November 28, 2018
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2022
Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2021
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Nature Medicine
|
October 13, 2020
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Jianjun Gao, Neema Navai, Omar Alhalabi, et al.
Nature
|
November 28, 2014
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M Gubin, Xiuli Zhang, Heiko Schuster, et al.
Cancer Discovery
|
December 1, 2020
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
Spencer C Wei, Wouter C Meijers, Margaret L Axelrod, et al.
Nature Communications
|
August 20, 2021
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
Tina Cascone, Annikka Weissferdt, Myrna C B Godoy, et al.
Page
of 65